163 related articles for article (PubMed ID: 18692341)
1. Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections.
Rogers GB; Stressmann FA; Koller G; Daniels T; Carroll MP; Bruce KD
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):133-41. PubMed ID: 18692341
[TBL] [Abstract][Full Text] [Related]
2. Comparison of propidium monoazide with ethidium monoazide for differentiation of live vs. dead bacteria by selective removal of DNA from dead cells.
Nocker A; Cheung CY; Camper AK
J Microbiol Methods; 2006 Nov; 67(2):310-20. PubMed ID: 16753236
[TBL] [Abstract][Full Text] [Related]
3. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis.
Rogers GB; Carroll MP; Serisier DJ; Hockey PM; Jones G; Kehagia V; Connett GJ; Bruce KD
J Clin Microbiol; 2006 Jul; 44(7):2601-4. PubMed ID: 16825392
[TBL] [Abstract][Full Text] [Related]
4. Improving clinical significance of PCR: use of propidium monoazide to distinguish viable from dead Staphylococcus aureus and Staphylococcus epidermidis.
Kobayashi H; Oethinger M; Tuohy MJ; Hall GS; Bauer TW
J Orthop Res; 2009 Sep; 27(9):1243-7. PubMed ID: 19322790
[TBL] [Abstract][Full Text] [Related]
5. Distinction between intact and antibiotic-inactivated bacteria by real-time PCR after treatment with propidium monoazide.
Kobayashi H; Oethinger M; Tuohy MJ; Hall GS; Bauer TW
J Orthop Res; 2010 Sep; 28(9):1245-51. PubMed ID: 20186836
[TBL] [Abstract][Full Text] [Related]
6. The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples.
Rogers GB; Marsh P; Stressmann AF; Allen CE; Daniels TV; Carroll MP; Bruce KD
Clin Microbiol Infect; 2010 Nov; 16(11):1656-8. PubMed ID: 20148918
[TBL] [Abstract][Full Text] [Related]
7. Molecular monitoring of disinfection efficacy using propidium monoazide in combination with quantitative PCR.
Nocker A; Sossa KE; Camper AK
J Microbiol Methods; 2007 Aug; 70(2):252-60. PubMed ID: 17544161
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the bacterial microbiome in first-pass meconium using propidium monoazide (PMA) to exclude nonviable bacterial DNA.
Stinson LF; Keelan JA; Payne MS
Lett Appl Microbiol; 2019 May; 68(5):378-385. PubMed ID: 30674082
[TBL] [Abstract][Full Text] [Related]
9. Selective detection of live bacteria combining propidium monoazide sample treatment with microarray technology.
Nocker A; Mazza A; Masson L; Camper AK; Brousseau R
J Microbiol Methods; 2009 Mar; 76(3):253-61. PubMed ID: 19103234
[TBL] [Abstract][Full Text] [Related]
10. Selective detection of viable Helicobacter pylori using ethidium monoazide or propidium monoazide in combination with real-time polymerase chain reaction.
Nam S; Kwon S; Kim MJ; Chae JC; Jae Maeng P; Park JG; Lee GC
Microbiol Immunol; 2011 Dec; 55(12):841-6. PubMed ID: 22004535
[TBL] [Abstract][Full Text] [Related]
11. Unsuitable distinction between viable and dead Staphylococcus aureus and Staphylococcus epidermidis by ethidium bromide monoazide.
Kobayashi H; Oethinger M; Tuohy MJ; Hall GS; Bauer TW
Lett Appl Microbiol; 2009 May; 48(5):633-8. PubMed ID: 19416465
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the microbiota of sputum samples from patients with lower respiratory tract infections.
Zhou Y; Lin P; Li Q; Han L; Zheng H; Wei Y; Cui Z; Ni Y; Guo X
Acta Biochim Biophys Sin (Shanghai); 2010 Oct; 42(10):754-61. PubMed ID: 20823075
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent amplified fragment length polymorphism (FAFLP) based molecular epidemiology of hospital infections in a tertiary care setting in Hyderabad, India.
Kenchappa P; Rao KR; Ahmed N; Joshi S; Ghousunnissa S; Vijayalakshmi V; Murthy KJ
Infect Genet Evol; 2006 May; 6(3):220-7. PubMed ID: 16054876
[TBL] [Abstract][Full Text] [Related]
14. Quantifying fungal viability in air and water samples using quantitative PCR after treatment with propidium monoazide (PMA).
Vesper S; McKinstry C; Hartmann C; Neace M; Yoder S; Vesper A
J Microbiol Methods; 2008 Feb; 72(2):180-4. PubMed ID: 18160156
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ethidium monoazide and propidium monoazide for the selective detection of viable Legionella cells.
Chang B; Taguri T; Sugiyama K; Amemura-Maekawa J; Kura F; Watanabe H
Jpn J Infect Dis; 2010 Mar; 63(2):119-23. PubMed ID: 20332575
[TBL] [Abstract][Full Text] [Related]
16. Use of propidium monoazide and increased amplicon length reduce false-positive signals in quantitative PCR for bioburden analysis.
Schnetzinger F; Pan Y; Nocker A
Appl Microbiol Biotechnol; 2013 Mar; 97(5):2153-62. PubMed ID: 23354451
[TBL] [Abstract][Full Text] [Related]
17. Use of propidium monoazide and quantitative PCR for differentiation of viable Escherichia coli from E. coli killed by mild or pasteurizing heat treatments.
Yang X; Badoni M; Gill CO
Food Microbiol; 2011 Dec; 28(8):1478-82. PubMed ID: 21925032
[TBL] [Abstract][Full Text] [Related]
18. Sodium chloride affects propidium monoazide action to distinguish viable cells.
Barth VC; Cattani F; Ferreira CA; de Oliveira SD
Anal Biochem; 2012 Sep; 428(2):108-10. PubMed ID: 22728959
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.
Spasenovski T; Carroll MP; Payne MS; Bruce KD
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):261-7. PubMed ID: 19216939
[TBL] [Abstract][Full Text] [Related]
20. Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation.
Nguyen LD; Deschaght P; Merlin S; Loywick A; Audebert C; Van Daele S; Viscogliosi E; Vaneechoutte M; Delhaes L
PLoS One; 2016; 11(12):e0168860. PubMed ID: 28030619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
